Marcus Corp

The stock remains in a Stage 2 advancing uptrend bolstered by a Parabola continuation pattern and rising EMAs. Price is currently extended well above the 9/21/50 EMAs at extreme overbought levels, making immediate execution unfavorable. We defer and look to stalk for a deeper pullback into rising EMA and prior resistance-turned-support zones. Medium-term bias stays bullish, but lower-risk entries require a meaningful retracement.

• ↑Consolidated revenue rose 3.8% YoY to $154.4M, driven by 6.4% theater growth to $92.9M
• ↑Adjusted EBITDA rebounded to $2.6M in Q1 despite five fewer operating days
• ↓Trading at 47.8x trailing P/E and 44.1x forward P/E suggests stretched valuation